Research·October 23, 2026 at 7:30 AM EDT·1 source
Novartis’ Kisqali Cuts Death Risk 19% in Breast Cancer Study
NVS -3.3%
NVS · last 30 trading days-1.8% since the news
News
What happened
- Novartis said Kisqali helped patients with a common form of early-stage breast cancer live longer.
- The study found Kisqali cut the risk of death by 19%.
- The findings support using Kisqali before the cancer returns.
Reduction in death risk
19%
Why it matters
The results could strengthen Kisqali’s position in early-stage breast cancer treatment and support Novartis’s oncology business.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 13Novartis quietly returns a key antibiotic to US market
- EarlierOct 16Novartis scraps Fabhalta study in lupus nephritis
- EarlierOct 22Roche talks up Phase 3 success rate as it unveils pipeline cuts
- First reported by BloombergOct 23Novartis’ Kisqali Cuts Death Risk 19% in Breast Cancer Study
Sources (1)
- BloombergOct 23Novartis’ Kisqali Cuts Death Risk 19% in Breast Cancer Study
Related
- Oct 23 · Bristol Myers reveals autoimmune CAR-T trial death, explains summertime pause
- Oct 23 · Novartis multiple sclerosis treatment cuts rates of relapse in pivotal trials
- Oct 23 · Novartis Multiple Sclerosis Pill Missed Expectations in Key Study
- Oct 22 · Roche talks up Phase 3 success rate as it unveils pipeline cuts
- Oct 16 · Novartis scraps Fabhalta study in lupus nephritis
- Oct 13 · Novartis quietly returns a key antibiotic to US market
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.